159 related articles for article (PubMed ID: 31556792)
1. Generalized Linear Models for Flexible Parametric Modeling of the Hazard Function.
Kearns B; Stevenson MD; Triantafyllopoulos K; Manca A
Med Decis Making; 2019 Oct; 39(7):867-878. PubMed ID: 31556792
[No Abstract] [Full Text] [Related]
2. Comparing current and emerging practice models for the extrapolation of survival data: a simulation study and case-study.
Kearns B; Stevenson MD; Triantafyllopoulos K; Manca A
BMC Med Res Methodol; 2021 Nov; 21(1):263. PubMed ID: 34837957
[TBL] [Abstract][Full Text] [Related]
3. The Extrapolation Performance of Survival Models for Data With a Cure Fraction: A Simulation Study.
Kearns B; Stevenson MD; Triantafyllopoulos K; Manca A
Value Health; 2021 Nov; 24(11):1634-1642. PubMed ID: 34711364
[TBL] [Abstract][Full Text] [Related]
4. Dynamic and Flexible Survival Models for Extrapolation of Relative Survival: A Case Study and Simulation Study.
Kearns B; Stevenson MD; Triantafyllopoulos K; Manca A
Med Decis Making; 2022 Oct; 42(7):945-955. PubMed ID: 35769004
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of survival extrapolation in immuno-oncology using multiple pre-planned data cuts: learnings to aid in model selection.
Bullement A; Willis A; Amin A; Schlichting M; Hatswell AJ; Bharmal M
BMC Med Res Methodol; 2020 May; 20(1):103. PubMed ID: 32375680
[TBL] [Abstract][Full Text] [Related]
6. Extrapolation of Survival Curves Using Standard Parametric Models and Flexible Parametric Spline Models: Comparisons in Large Registry Cohorts with Advanced Cancer.
Gray J; Sullivan T; Latimer NR; Salter A; Sorich MJ; Ward RL; Karnon J
Med Decis Making; 2021 Feb; 41(2):179-193. PubMed ID: 33349137
[TBL] [Abstract][Full Text] [Related]
7. Comparing Survival Extrapolation within All-Cause and Relative Survival Frameworks by Standard Parametric Models and Flexible Parametric Spline Models Using the Swedish Cancer Registry.
Chen EY; Leontyeva Y; Lin CN; Wang JD; Clements MS; Dickman PW
Med Decis Making; 2024 Apr; 44(3):269-282. PubMed ID: 38314657
[TBL] [Abstract][Full Text] [Related]
8. Novel and existing flexible survival methods for network meta-analyses.
Heeg B; Garcia A; Beekhuizen SV; Verhoek A; Oostrum IV; Roychoudhury S; Cappelleri JC; Postma MJ; Nicolaas Martinus Ouwens MJ
J Comp Eff Res; 2022 Sep; ():. PubMed ID: 36093741
[No Abstract] [Full Text] [Related]
9. Generalized survival models for correlated time-to-event data.
Liu XR; Pawitan Y; Clements MS
Stat Med; 2017 Dec; 36(29):4743-4762. PubMed ID: 28905409
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Flexible Parametric Relative Survival Approaches for Enforcing Long-Term Constraints When Extrapolating All-Cause Survival.
Lee S; Lambert PC; Sweeting MJ; Latimer NR; Rutherford MJ
Value Health; 2024 Jan; 27(1):51-60. PubMed ID: 37858887
[TBL] [Abstract][Full Text] [Related]
11. Survival Extrapolation Incorporating General Population Mortality Using Excess Hazard and Cure Models: A Tutorial.
Sweeting MJ; Rutherford MJ; Jackson D; Lee S; Latimer NR; Hettle R; Lambert PC
Med Decis Making; 2023 Aug; 43(6):737-748. PubMed ID: 37448102
[TBL] [Abstract][Full Text] [Related]
12. Log-normal frailty models fitted as Poisson generalized linear mixed models.
Hirsch K; Wienke A; Kuss O
Comput Methods Programs Biomed; 2016 Dec; 137():167-175. PubMed ID: 28110722
[TBL] [Abstract][Full Text] [Related]
13. Nonproportional Hazards in Network Meta-Analysis: Efficient Strategies for Model Building and Analysis.
Wiksten A; Hawkins N; Piepho HP; Gsteiger S
Value Health; 2020 Jul; 23(7):918-927. PubMed ID: 32762994
[TBL] [Abstract][Full Text] [Related]
14. Parametric and penalized generalized survival models.
Liu XR; Pawitan Y; Clements M
Stat Methods Med Res; 2018 May; 27(5):1531-1546. PubMed ID: 27587596
[TBL] [Abstract][Full Text] [Related]
15. Ecotoxicology is not normal: A comparison of statistical approaches for analysis of count and proportion data in ecotoxicology.
Szöcs E; Schäfer RB
Environ Sci Pollut Res Int; 2015 Sep; 22(18):13990-9. PubMed ID: 25953608
[TBL] [Abstract][Full Text] [Related]
16. Performance Evaluation of Parametric and Nonparametric Methods When Assessing Effect Measure Modification.
Conzuelo Rodriguez G; Bodnar LM; Brooks MM; Wahed A; Kennedy EH; Schisterman E; Naimi AI
Am J Epidemiol; 2022 Jan; 191(1):198-207. PubMed ID: 34409985
[TBL] [Abstract][Full Text] [Related]
17. Estimating Lifetime Benefits Associated with Immuno-Oncology Therapies: Challenges and Approaches for Overall Survival Extrapolations.
Ouwens MJNM; Mukhopadhyay P; Zhang Y; Huang M; Latimer N; Briggs A
Pharmacoeconomics; 2019 Sep; 37(9):1129-1138. PubMed ID: 31102143
[TBL] [Abstract][Full Text] [Related]
18. A flexible parametric approach to examining spatial variation in relative survival.
Cramb SM; Mengersen KL; Lambert PC; Ryan LM; Baade PD
Stat Med; 2016 Dec; 35(29):5448-5463. PubMed ID: 27503837
[TBL] [Abstract][Full Text] [Related]
19. Impact of model misspecification in shared frailty survival models.
Gasparini A; Clements MS; Abrams KR; Crowther MJ
Stat Med; 2019 Oct; 38(23):4477-4502. PubMed ID: 31328285
[TBL] [Abstract][Full Text] [Related]
20. Direct Incorporation of Expert Opinion into Parametric Survival Models to Inform Survival Extrapolation.
Cooney P; White A
Med Decis Making; 2023 Apr; 43(3):325-336. PubMed ID: 36647200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
